
Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
Keywords: داخل وریدی; Inflammatory Bowel Disease; Fully Human Monoclonal Antibody; Randomized Withdrawal Trial; IV; intravenous; NNT; number needed to treat; PURSUIT; Program of Ulcerative Colitis Research Studies Utilizing an Investigational Treatment; PURSUIT-M; Program of U